Search Results - "Weinblatt, Michael E."

Methotrexate: who would have predicted its importance in rheumatoid arthritis? by Weinblatt, Michael E

Get full text

Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study by Desai, Rishi J., Pawar, Ajinkya, Weinblatt, Michael E., Kim, Seoyoung C.

“…Objective To evaluate the risk of venous thromboembolism (VTE) in rheumatoid arthritis (RA) patients receiving tofacitinib versus those receiving tumor…”
Get full text

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis by Taylor, Peter C, Keystone, Edward C, van der Heijde, Désirée, Weinblatt, Michael E, del Carmen Morales, Liliana, Reyes Gonzaga, Jaime, Yakushin, Sergey, Ishii, Taeko, Emoto, Kahaku, Beattie, Scott, Arora, Vipin, Gaich, Carol, Rooney, Terence, Schlichting, Douglas, Macias, William L, de Bono, Stephanie, Tanaka, Yoshiya

“…In a phase 3 randomized trial of 1307 patients with rheumatoid arthritis receiving background methotrexate, the oral JAK1 and JAK2 inhibitor baricitinib showed…”
Get full text

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3 by Mikuls, Ted R., Johnson, Sindhu R., Fraenkel, Liana, Arasaratnam, Reuben J., Baden, Lindsey R., Bermas, Bonnie L., Chatham, Winn, Cohen, Stanley, Costenbader, Karen, Gravallese, Ellen M., Kalil, Andre C., Weinblatt, Michael E., Winthrop, Kevin, Mudano, Amy S., Turner, Amy, Saag, Kenneth G.

“…Objective To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19)…”
Get full text

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial by Schiff, Michael, Weinblatt, Michael E, Valente, Robert, van der Heijde, Désirée, Citera, Gustavo, Elegbe, Ayanbola, Maldonado, Michael, Fleischmann, Roy

“…To compare over 2 years the safety, efficacy and radiographic outcomes of subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in…”
Get more information

Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort Study by Sparks, Jeffrey A., He, Xintong, Huang, Jie, Fletcher, Elaine A., Zaccardelli, Alessandra, Friedlander, H. Maura, Gill, Ritu R., Hatabu, Hiroto, Nishino, Mizuki, Murphy, David J., Iannaccone, Christine K., Mahmoud, Taysir G., Frits, Michelle L., Lu, Bing, Rosas, Ivan O., Dellaripa, Paul F., Weinblatt, Michael E., Karlson, Elizabeth W., Shadick, Nancy A., Doyle, Tracy J.

“…Objective To evaluate rheumatoid arthritis (RA) disease activity and risk of RA‐associated interstitial lung disease (RA‐ILD). Methods We investigated disease…”
Get full text

Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study by Weinblatt, Michael E., Schiff, Michael, Valente, Robert, van der Heijde, Désirée, Citera, Gustavo, Zhao, Cathy, Maldonado, Michael, Fleischmann, Roy

“…Objective There is a need for comparative studies to provide evidence‐based treatment guidance for biologic agents in rheumatoid arthritis (RA). Therefore,…”
Get full text

Principal components analysis corrects for stratification in genome-wide association studies by Price, Alkes L, Patterson, Nick J, Plenge, Robert M, Weinblatt, Michael E, Shadick, Nancy A, Reich, David

“…Population stratification--allele frequency differences between cases and controls due to systematic ancestry differences-can cause spurious associations in…”
Get full text

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2 by Mikuls, Ted R., Johnson, Sindhu R., Fraenkel, Liana, Arasaratnam, Reuben J., Baden, Lindsey R., Bermas, Bonnie L., Chatham, Winn, Cohen, Stanley, Costenbader, Karen, Gravallese, Ellen M., Kalil, Andre C., Weinblatt, Michael E., Winthrop, Kevin, Mudano, Amy S., Turner, Amy, Saag, Kenneth G.

“…Objective To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19)…”
Get full text

Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production by Boilard, Eric, Nigrovic, Peter A, Larabee, Katherine, Watts, Gerald F.M, Coblyn, Jonathan S, Weinblatt, Michael E, Massarotti, Elena M, Remold-O'Donnell, Eileen, Farndale, Richard W, Ware, Jerry, Lee, David M

“…In addition to their pivotal role in thrombosis and wound repair, platelets participate in inflammatory responses. We investigated the role of platelets in the…”
Get full text

Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial by Botson, John K, Obermeyer, Katie, LaMoreaux, Brian, Zhao, Lin, Weinblatt, Michael E, Peterson, Jeff

“…Uncontrolled/refractory gout patients are recalcitrant/intolerant to oral urate-lowering therapies (ULTs), experiencing frequent gout flares, functionally…”
Get full text

A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis by Weinblatt, Michael E., McInnes, Iain B., Kremer, Joel M., Miranda, Pedro, Vencovsky, Jiri, Guo, Xiang, White, Wendy I., Ryan, Patricia C., Godwood, Alex, Albulescu, Marius, Close, David, Burmester, Gerd R.

“…Objective This 24‐week, phase IIb, double‐blind study was undertaken to evaluate the efficacy and safety of mavrilimumab (a monoclonal antibody to…”
Get full text

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019 by Winthrop, Kevin L, Weinblatt, Michael E, Bathon, Joan, Burmester, Gerd R, Mease, Philip J, Crofford, Leslie, Bykerk, Vivian, Dougados, Maxime, Rosenbaum, James Todd, Mariette, Xavier, Sieper, Joachim, Melchers, Fritz, Cronstein, Bruce N, Breedveld, Ferry C, Kalden, Joachim, Smolen, Josef S, Furst, Daniel

“…To detail the greatest areas of unmet scientific and clinical needs in rheumatology. The 21st annual international Advances in Targeted Therapies meeting…”
Get more information

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers by Doyle, Tracy J, Patel, Avignat S, Hatabu, Hiroto, Nishino, Mizuki, Wu, Guodong, Osorio, Juan C, Golzarri, Maria F, Traslosheros, Andres, Chu, Sarah G, Frits, Michelle L, Iannaccone, Christine K, Koontz, Diane, Fuhrman, Carl, Weinblatt, Michael E, El-Chemaly, Souheil Y, Washko, George R, Hunninghake, Gary M, Choi, Augustine M K, Dellaripa, Paul F, Oddis, Chester V, Shadick, Nancy A, Ascherman, Dana P, Rosas, Ivan O

“…Interstitial lung disease (ILD), a leading cause of morbidity and mortality in rheumatoid arthritis (RA), is highly prevalent, yet RA-ILD is underrecognized…”
Get full text

Validation of rheumatoid arthritis diagnoses in health care utilization data by Kim, Seo Young, Servi, Amber, Polinski, Jennifer M, Mogun, Helen, Weinblatt, Michael E, Katz, Jeffrey N, Solomon, Daniel H

“…Health care utilization databases have been increasingly used for studies of rheumatoid arthritis (RA). However, the accuracy of RA diagnoses in these data has…”
Get full text

Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis by Das, Priyam, Weisenfeld, Dana, Dahal, Kumar, De, Debsurya, Feathers, Vivi, Coblyn, Jonathan S, Weinblatt, Michael E, Shadick, Nancy A, Cai, Tianxi, Liao, Katherine P

“…Many patients with rheumatoid arthritis (RA) require a trial of multiple biologic disease-modifying anti-rheumatic drugs (bDMARDs) to control their disease…”
Get full text

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort by Lillegraven, Siri, Prince, Femke H M, Shadick, Nancy A, Bykerk, Vivian P, Lu, Bing, Frits, Michelle L, Iannaccone, Christine K, Kvien, Tore K, Haavardsholm, Espen A, Weinblatt, Michael E, Solomon, Daniel H

“…One goal of remission in rheumatoid arthritis (RA) is to halt joint damage. The authors assessed the progression of radiographic joint damage among RA patients…”
Get more information

Safety of the Zoster Vaccine Recombinant Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center's Experience With 400 Patients by Stevens, Emma, Weinblatt, Michael E., Massarotti, Elena, Griffin, Frances, Emani, Srinivas, Desai, Sonali

“…Objective Patients with rheumatoid arthritis (RA) and other systemic rheumatic diseases (SRDs) are at increased risk of developing herpes zoster (HZ). Zoster…”
Get full text

Functional Impact of a Spectrum of Interstitial Lung Abnormalities in Rheumatoid Arthritis by Doyle, Tracy J., MD, MPH, Dellaripa, Paul F., MD, Batra, Kerri, MD, Frits, Michelle L., BA, Iannaccone, Christine K., MPH, Hatabu, Hiroto, MD, PhD, Nishino, Mizuki, MD, Weinblatt, Michael E., MD, Ascherman, Dana P., MD, Washko, George R., MD, MMSc, Hunninghake, Gary M., MD, MPH, Choi, Augustine M.K., MD, Shadick, Nancy A., MD, MPH, Rosas, Ivan O., MD, FCCP

“…BACKGROUND Approximately 10% of patients with rheumatoid arthritis (RA) have interstitial lung disease (ILD), and one-third have subclinical ILD on chest CT…”
Get full text

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity by Curtis, Jeffrey R., van der Helm‐van Mil, Annette H., Knevel, Rachel, Huizinga, Tom W., Haney, Douglas J., Shen, Yijing, Ramanujan, Saroja, Cavet, Guy, Centola, Michael, Hesterberg, Lyndal K., Chernoff, David, Ford, Kerri, Shadick, Nancy A., Hamburger, Max, Fleischmann, Roy, Keystone, Edward, Weinblatt, Michael E.

“…Objective Quantitative assessment of disease activity in rheumatoid arthritis (RA) is important for patient management, and additional objective information…”
Get full text